| Percutaneous treatment of hepatocellular carcinoma: state of the art and innovations JC Nault, O Sutter, P Nahon, N Ganne-Carrié, O Séror Journal of hepatology 68 (4), 783-797, 2018 | 400 | 2018 |
| Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC A Hocquelet, C Aubé, A Rode, V Cartier, O Sutter, AF Manichon, ... Journal of hepatology 66 (1), 67-74, 2017 | 165 | 2017 |
| Safety and efficacy of irreversible electroporation for the treatment of hepatocellular carcinoma not amenable to thermal ablation techniques: a retrospective single-center … O Sutter, J Calvo, G N’Kontchou, JC Nault, R Ourabia, P Nahon, ... Radiology 284 (3), 877-886, 2017 | 156 | 2017 |
| New concepts in the treatment of hepatocellular carcinoma S Sidali, E Trépo, O Sutter, JC Nault United European Gastroenterology Journal 10 (7), 765-774, 2022 | 72 | 2022 |
| Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs A Paisant, V Vilgrain, J Riou, F Oberti, O Sutter, V Laurent, A Rodes, ... Journal of hepatology 72 (5), 937-945, 2020 | 71 | 2020 |
| Molecular classification of hepatocellular adenomas: impact on clinical practice AL Védie, O Sutter, M Ziol, JC Nault Hepatic oncology 5 (1), HEP04, 2018 | 45 | 2018 |
| Combination of Model for End‐Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory … A Walter, M Rudler, P Olivas, L Moga, E Trépo, MA Robic, ... Hepatology 74 (4), 2085-2101, 2021 | 38 | 2021 |
| Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab–bevacizumab C Campani, J Bamba‐Funck, B Campion, S Sidali, L Blaise, ... Liver International 43 (3), 708-717, 2023 | 34 | 2023 |
| TIPS for management of portal-hypertension-related complications in patients with cirrhosis M Allaire, A Walter, O Sutter, P Nahon, N Ganne-Carrié, R Amathieu, ... Clinics and research in hepatology and gastroenterology 44 (3), 249-263, 2020 | 32 | 2020 |
| Multibipolar Radiofrequency Ablation for the Treatment of Mass-Forming and Infiltrative Hepatocellular Carcinomas> 5 cm: Long-Term Results G N’Kontchou, JC Nault, O Sutter, V Bourcier, E Coderc, V Grando, ... Liver Cancer 8 (3), 172-185, 2019 | 31 | 2019 |
| No-touch multi-bipolar radiofrequency ablation for the treatment of subcapsular hepatocellular carcinoma≤ 5 cm not puncturable via the non-tumorous liver parenchyma A Petit, A Hocquelet, G N’kontchou, E Varin, N Sellier, O Seror, O Sutter CardioVascular and Interventional Radiology 43, 273-283, 2020 | 25 | 2020 |
| Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis GS Roth, M Benhamou, Y Teyssier, A Seigneurin, M Abousalihac, ... Cancers 13 (4), 812, 2021 | 19 | 2021 |
| Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis M Allaire, S Rekik, R Layese, A Mumana, E Guyot, G Nkontchou, ... Digestive and Liver Disease 51 (1), 86-94, 2019 | 19 | 2019 |
| Diffusion-weighted MR imaging of uterine leiomyomas following uterine artery embolization O Sutter, P Soyer, E Shotar, R Dautry, Y Guerrache, V Placé, R Opréa, ... European radiology 26, 3558-3570, 2016 | 17 | 2016 |
| Real-Time 3D Virtual Target Fluoroscopic Display for Challenging Hepatocellular Carcinoma Ablations Using Cone Beam CT O Sutter, A Fihri, R Ourabia-Belkacem, N Sellier, A Diallo, O Seror Technology in cancer research & treatment 17, 1533033818789634, 2018 | 16 | 2018 |
| Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non‐alcoholic fatty liver disease N Nguyen, A Rode, H Trillaud, C Aubé, AF Manichon, A Hocquelet, ... Liver International 42 (4), 905-917, 2022 | 14 | 2022 |
| Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization G Roth, Y Teyssier, M Benhamou, M Abousalihac, S Caruso, C Sengel, ... World Journal of Gastroenterology 28 (36), 5324, 2022 | 12 | 2022 |
| Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab C Campani, A Vallot, H Ghannouchi, M Allaire, M Evain, P Sultanik, ... Hepatology 79 (1), 49-60, 2024 | 10 | 2024 |
| Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuation A Demory, JM Péron, J Calderaro, J Selves, FZ Mokrane, G Amaddeo, ... Hepatology 77 (2), 430-442, 2023 | 10 | 2023 |
| Combination of MELD and lactate predicts death in patients treated with salvage TIPS for refractory variceal bleeding A Walter, M Rudler, P Olivas, L Moga, E Trépo, MA Robic, ... Hepatology 74 (4), 2085-101, 2021 | 10 | 2021 |
